Life Sciences

A protein called TWIST1 strengthens dangerous plaques in arteries rather than destabilizing them, a counterintuitive finding that could reshape how cardiologists approach atherosclerosis treatment. The discovery, published in Nature Communications, suggests blocking this protein might not prevent heart attacks as previously assumed.EN

Researchers identified a subset of pancreatic cancers that survive chemotherapy by activating a cellular stress mechanism, then tricking surrounding fibroblasts into feeding them amino acids they can't make themselves. The finding opens a new drug target and explains why some tumors resist treatment—potentially reshaping how oncologists approach resistant cancers.EN

Scientists identified how overactive Smad7 protein in intestinal cells disrupts purine metabolism and sparks chronic inflammation resembling Crohn's disease. The finding, validated in patient tissue, points to a new drug target for IBD treatments and suggests metabolic interventions could offer an alternative to current immune-suppressing therapies.EN

Researchers have developed tissue culture techniques to propagate caper plants (Capparis spinosa) in controlled laboratory settings, overcoming the crop's naturally slow growth and poor seed viability. The breakthrough enables producers to generate genetically identical plants rapidly, opening commercial opportunities in regions where traditional cultivation has proved economically unfeasible.EN

Researchers mapped how demographic factors and genetic variants fundamentally alter which viral threats a person's antibodies recognize. The findings could reshape vaccine design strategies and explain why immunization effectiveness varies dramatically across populations—with major implications for public health planning and pharmaceutical development.EN

Researchers have optimized a clean extraction technique to harvest betulin, a high-value compound with proven anti-inflammatory and anticancer properties, from birch bark—a byproduct currently discarded by the timber industry. The breakthrough could create a profitable secondary revenue stream for wood processors while reducing waste.EN

Researchers combined a viral vector delivering immune-boosting genes with an existing checkpoint inhibitor to achieve responses in advanced melanoma patients who had failed standard treatment. The approach—injecting genes directly into tumors—offers a potential path forward for the thousands of patients who become resistant to PD-1 drugs, a critical unmet need in oncology.EN

Levande cancerterapier baserade på bakterier, virus och mikrobiom öppnar nya vägar för urinblåsecancer där konventionella behandlingar misslyckas. Framför allt BCG och utvalda onkolytiska virusplattformar har uppnått klinisk tillämpning, men behovet av effektivare strategier för BCG-resistenta patienter är brådskande. Recensionen identifierar fem överlappande mekanismer: direkt tumördödsfall genom bakteriell kolonisering, immunaktivering, programmerad läkemedelsleverans via genetisk konstruering, virusmedierad tumörlysis och mikrobiommodulering. Dessa oncobiotics kan överkomma begränsningar hos befintliga terapi genom att utnyttja blåsans tillgänglighet för lokal behandling. Institutioner som Sahlgrenska och University of Gothenburg bidrar till denna utveckling. Även om de mest avancerade systemen fortfarande befinner sig i preklinisk fas, accelererar framsteg inom syntetisk biologi utvecklingen. FoU-investerare bör notera att detta område erbjuder möjligheter för tidig positionering innan regulatoriska vägar etableras.

**Akustisk övervakning avslöjar neonikotinoid-skador på myror redan under miljöreleveanta doser** Metod för att tidigt detektera pesticidbuskador på mark-levande insekter har saknats. Svenska forskare vid Umeå universitet demonstrerar att ljudinspelningar kan avslöja subletala beteendeförändringar i rödmyrkoloniers (Formica rufa) aktivitet orsakade av imidakloprid. Kolonier exponerade för miljöreleveanta imidaklopridhalter (10,8 ± 5,7 ng g⁻¹) visade ökad aktivitet inom sex timmar, följt av långsam återhämtning över en vecka. Metoden lyckades upptäcka denna långtidseffekt trots myrornas underjordiska miljö — något andra tekniker missat. Forskargruppen inkluderade Svenska lantbruksuniversitetet, NORCE Research AS och Species360. Akustisk övervakning möjliggör icke-invasiv fältövervakning av skadliga effekter och kan bli ett verktyg för regulatorisk miljötestning av kemikalier. Resultaten väcker frågor om neonikotinoidernas påverkan på pollinerare och markekosystem vid låga expositionsnivåer.

Researchers have developed a virtual testing environment that lets manufacturers safely evaluate how robots and human workers interact before deploying them on real factory floors. The platform cuts development time and liability risk, potentially accelerating adoption of collaborative robotics in warehouses and production facilities worldwide.EN

Researchers identified molecular signals in tiny particles circulating in blood that prepare distant organs to receive cancer cells—a process called pre-metastatic niche formation. The discovery could enable earlier detection of patients at high relapse risk after surgery and potentially lead to therapies that block metastasis before it starts.EN

Researchers discovered that mezigdomide can restore exhausted T cells—immune soldiers that lose fighting power against cancer—by targeting two key proteins that shut down their activity. The finding could overcome a major barrier limiting the effectiveness of immunotherapies in multiple myeloma, potentially expanding treatment options for patients who develop resistance.EN

Researchers are advancing CAR-T cells, oncolytic viruses, and engineered bacteria as cancer treatments that fight tumors while boosting immune response. While these approaches show real promise in blood cancers, solid tumors remain difficult to treat—a bottleneck that will determine whether biotech companies can expand these therapies into blockbuster markets.EN

Scientists discovered that two genes linked to aggressive blood cancers produce alternative protein versions controlled by hidden internal promoters—a finding that could enable earlier AML detection and improve diagnosis across multiple cancer types. The tissue-specific patterns suggest these protein variants may serve as reliable biomarkers for identifying which patients face the poorest prognosis.EN

Researchers propose the cerebellum controls walking through simple, hardwired neural architecture rather than learning—overturning decades of mainstream neuroscience. The finding could reshape how companies develop brain-computer interfaces, prosthetics, and neuromorphic AI systems, potentially unlocking cheaper, more efficient designs based on biological principles overlooked for years.EN

Researchers developed a platelet-coated nanoparticle that delivers clot-busting drugs more safely and effectively in stroke models, potentially addressing the narrow therapeutic window that restricts current FDA-approved treatments. The approach reduced bleeding complications while improving blood flow recovery—key barriers that could expand treatment eligibility and reshape the stroke care market if human trials succeed.EN

Scientists are developing new treatments targeting astrocytes—support cells in the brain—to address neurological conditions. The work could open a significant new market for brain therapies and reshape how neurological diseases are treated clinically.EN

Researchers have developed a carbon nanotube-based hydrogel that can reliably record brain activity from inside the ear canal, potentially creating a new category of discreet wearable neurotechnology. The advance could enable continuous monitoring of infants, elderly patients, and others who cannot tolerate traditional headsets, opening a significant market for brain-computer interfaces and clinical diagnostics.EN

Researchers combined deep learning with retrobiosynthesis to systematically catalog how yeast cells convert chemicals—uncovering metabolic routes that standard methods miss. The advance could accelerate development of engineered microbes for biomanufacturing drugs, fuels, and specialty chemicals at lower cost.EN

Researchers found that common particles shed from spinal implants—silicon nitride, cobalt oxide, and chromium oxide—don't activate dangerous inflammatory reactions in brain cells. The finding could accelerate approval of next-generation implant materials and reduce long-term safety liability for device manufacturers.EN

Researchers propose combining blood biopsies with genetic mutation analysis to catch tumors earlier and match patients to treatments more precisely. The approach could unlock personalized cancer care for patients whose tumors lack known drug targets—potentially opening new markets for diagnostics and expanding treatment options across solid tumors.EN

Researchers have validated a simple blood-based technique for detecting calprotectin, a marker of airway inflammation, in sputum samples from patients with chronic lung disease. The finding could enable faster, more reliable diagnosis and monitoring of conditions like COPD and cystic fibrosis, potentially reducing hospital visits and treatment delays.EN

Researchers have created an automated system to dissect PROTACs—complex molecules designed to destroy disease-causing proteins—a task that previously required months of manual work. The breakthrough could accelerate drug discovery by years, though early versions struggle with truly novel molecular designs.EN

A new computational method reveals that conventional protein analysis systematically underestimates how actively enzymes break down proteins in cells. The technique could improve drug development, disease diagnostics, and efforts to engineer cells for manufacturing, by finally giving researchers an accurate picture of what's actually happening inside living systems.EN

Researchers have released Nallo, an open-source software pipeline that streamlines analysis of long-read DNA sequencing data—a technology increasingly used to diagnose rare genetic diseases. The tool automates what previously required significant manual work, potentially accelerating diagnoses and reducing costs for hospitals and diagnostic labs adopting advanced sequencing technologies.EN